TrakCel integrates product with cell and gene therapy platforms

Published: 25-Apr-2023

This integration extends the ecosystem to 12 integrated partners. A further four TrakCel partners are progressing through proof-of-concept integrations

TrakCel has updated its advanced therapy orchestration product OCELLOS, via additions to the TrakCel partner ecosystem.

The company’s ecosystem integrates the widest range of partners across the cell and gene therapy chain. TrakCel’s partners include couriers, CDMOs, clinical data system developers, patient hub services and CGT labelling systems. This integration extends the ecosystem to 12 integrated partners. A further four TrakCel partners are progressing through proof-of-concept integrations that are scheduled to be completed by the end of 2023. 

The latest update has integrations with decentralised clinical trial platforms and Enterprise Resource Planning (ERP) systems available, paving the way for the cell and gene therapy developers to work with these partners or integrate their own trial platforms or ERP systems with OCELLOS. The integration means that TrakCel’s OCELLOS is able to import, display and report on the data from both the clinical trial platform and ERP system.

This will be as important as a development to the delivery of therapies to patients as the discovery of the therapies themselves

“TrakCel has worked hard to select the right integration partners to develop a real eco-system that can serve the needs of the entire cell and gene therapy sector. This enables a true team of supply chain partners that can share information in real time and be informed by OCELLOS when there are changes,” said Chris Came, VP Global Alliances, TrakCel. “This will be as important as a development to the delivery of therapies to patients as the discovery of the therapies themselves.”

TrakCel has ensured the automated cross-platform transfer of data removes the need for manual transfer of information and files, reducing errors and management time. This will be vital for the cell and gene therapy sector, where real time updates and on demand data is critical to meeting process criteria and optimising time to treatment. Users receive automated notifications if a process is outside of stated parameters, or if there is an action that requires urgent attention.

Relevant companies

You may also like